This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

New Research Shows Moderately Obese Patients Can Benefit From The Work Of Dr. Feiz

LOS ANGELES, June 20, 2013 /PRNewswire/ -- The team at Dr. Feiz and Associates has become renowned for their life-changing weight loss surgeries. By performing procedures like sleeve gastrectomy, which involves removal of the hunger-stimulating ghrelin hormone from the stomach, the surgeons are able to help patients lose substantial amounts of weight without the discomfort of hunger pangs. While the benefits of weight-loss surgery for the extremely obese like gastric sleeve are well-documented, new research suggests that those who are only moderately obese may also experience significantly improved health.

For those suffering from mild or moderate obesity, new research shows that weight-loss surgery can improve type 2 diabetes, high blood pressure and high cholesterol more effectively than conventional diabetes management and lifestyle changes. "We're seeing a pattern in these studies. There's a definite impact on the diabetes after surgery. Some people don't respond so well, but most do," says Dr. Bruce Wolfe, a professor of surgery and co-director of bariatric surgery at Oregon Health & Science University in Portland. Normally, weight-loss surgeries are done on those with a BMI of 40 or above. However, if an individual has heart disease risk factors like type 2 diabetes, high blood pressure, high cholesterol or sleep apnea, a highly-trained bariatric surgeon like Dr. Feiz can achieve incredible results through bariatric surgery on an individual with a BMI of 35 or more.

Dr. Feiz and Associates is the practice of the renowned Michael Feiz, M.D., FACS. Prior to heading the exceptional team at Dr. Feiz and Associates, the accomplished surgeon completed an internship and residency at the famous Los Angeles County USC Medical Center as well as a fellowship at Cedars Sinai Medical Center. There, he received specialized training in bariatric and minimally invasive surgery, talents he puts to great use today as the head surgeon of a team of some of the finest weight-loss surgeons working today.  

"I think we found some promising results for the lower BMI patients with diabetes," says Dr. Melinda Maggard-Gibbons, associate professor with RAND Health in Santa Monica, CA. Dr. Maggard-Gibbons points out that "we need longer and larger studies" before we know for sure how sustainable the changes are, but for those who are mildly obese and looking for a way to bolster their health and life expectancy, it is encouraging news. For the moderately and extremely obese alike, the expert surgeons at Dr. Feiz and Associates can offer expert medical advice and, naturally, world-class surgical skill.  For a free consultation at Dr. Feiz and Associates, please call 310-817-6911 or visit the doctor's contact page at www.drfeiz.com. Dr. Feiz and his team are always eager to assist those in need of first-class weight loss solutions, so don't hesitate to call.

Release submitted by www.cyberset.com

SOURCE Dr. Feiz and Associates

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs